Research articles
ScienceAsia 48 (2022): 1-7 |doi:
10.2306/scienceasia1513-1874.2022.002
Jatupalathika herbal formula inhibits lipid accumulation and
induces lipolysis in 3T3-L1 adipocytes
Aurasorn Saraphanchotiwitthayaa,b,*, Pattana Sripalakitc
ABSTRACT: Jatupalathika is composed of four dried fruit of Terminalia bellerica (Gaertn.) Roxb, Terminalia chebula Retz. var. chebula, Terminalia arjuna Roxb., and Phyllanthus emblica L. This research aimed to investigate the anti-obesity potential of Jatupalathika aqueous extracts on the inhibition of fat accumulation and the induction of lipolysis in 3T3-L1 adipocytes, compared with individual herbs in the formula, gallic acid, and ellagic acid at a series of
concentrations of 10–100 µg/ml. The viability and proliferation of preadipocytes and differentiated adipocytes were analysed by the MTT technique. Lipid accumulation was measured by oil red O staining. The amount of triglycerides
and glycerol released in the medium was analysed by a colorimetric method. Compared with the control, Jatupalathika
extracts reduced fat accumulation (3.5 folds at 100 µg/ml) and triglyceride content (3 folds at 100 µg/ml), but increased glycerol release (4.5 folds at 10 µg/ml). These activities could be attributed to the synergy between gallic acid and other bioactive components in the formula. Moreover, Jatupalathika extract (100 µg/ml) decreased the %viability of both preadipocytes and differentiated adipocytes by 28.85 ± 1.87% and 32.36 ± 2.66%, respectively. It could be concluded that Jatupalathika extract effectively reduced fat accumulation by the inhibition of lipogenesis and adipogenesis and the induction of lipolysis, which could be related to the induction of cell apoptosis or a reduction in cell proliferation. This herbal formula might potentially be used in the prevention and treatment of obesity. However, further investigations on mechanism of action, in vivo effects, and toxicity of the formula need to be done.
Download PDF
228 Downloads 819 Views
| a |
Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok
65000 Thailand |
| b |
Pharmaceutical Biotechnology Research Unit, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok
65000 Thailand |
| c |
Department of Pharmaceutical Chemistry and Pharmacognosy, Faculty of Pharmaceutical Sciences, Naresuan
University, Phitsanulok 65000 Thailand |
* Corresponding author, E-mail: aurasorns@nu.ac.th
Received 3 Nov 2020, Accepted 10 Jun 2021
|
